Trials / Completed
CompletedNCT04260750
ICBT for Depression - A Factorial Investigation of Kinds of Therapist Support and Self-/Expert-selected Content
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 246 (actual)
- Sponsor
- Linkoeping University · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a factorial randomized controlled trial investigating the efficacy of difference versions of internet-administered cognitive behavioral therapy.
Detailed description
The study is a 2 x 2 design. The first factor thought to be of relevance for the efficacy is the whether the content is selected by the participants themselves or by a therapist. The second factor consists of two levels: regular, continuous weekly support from a therapist or guidance on demand by a health care team consisting of a physician, a nurse, a clinical psychologist, an IT-technician and the principal investigator of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Internet-administered Cognitive behavioral therapy (ICBT) | The intervention consists of fifteen modules, each having a specific focus on a problem (e.g. comorbid worry alongside the depression) or containing a specific strategy or element (e.g. behavioral activation). The fifteen modules are: Introduction/Psychoeducation about depression, Behavioral activation 1, Behavioral activation 2, Cognitive restructuring, Acceptance, Psychoeducation about emotions, Anxiety and exposure, Comorbid social anxiety, Comorbid worrying and generalized anxiety, Comorbid panic disorder, Sleep problems, Perfectionism, Stress management, Relaxation, and Relapse prevention. The first and last module are assigned to all participants. The rest is picked either by the participants themselves or by the therapist conducting the intake interview. |
Timeline
- Start date
- 2020-01-13
- Primary completion
- 2021-04-15
- Completion
- 2021-04-15
- First posted
- 2020-02-07
- Last updated
- 2021-04-20
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04260750. Inclusion in this directory is not an endorsement.